Category: Pharmaceuticals

Johnson & Johnson commits more than 238,000 violations of Arkansas’s Medicaid fraud laws

After an Arkansas jury found that Johnson & Johnson (JNJ) company officials misled doctors and patients about the risks of one of their drugs, a judge ruled that JNJ must pay more than $1.1 billion in fines. The drug was an antipsychotic medication called Risperdal. The jury had concluded that J&J’s marketing of this particular drug violated both Medicare fraud laws and Arkansas’s deceptive trade practices statutes.

California Medical Billing Company Resolves Allegations of False Claims to Federal Health Care Programs

The Justice Department announced today that Janzen, Johnston & Rockwell Emergency Medicine Management Services Inc. (JJ&R), who handles billing services for physicians, hospitals and other health care providers, was accused of submitting false claims to Medicare and Louisiana’s Medicaid program and has agreed to settle and pay the United States $4.6 million.

Supreme Court Rules that Laws Limiting Marketing Efforts of Drug Manufacturers Are a Violation of Free Speech

On Thursday, the United States Supreme Court struck down a Vermont law that blocked drug manufacturers’ use of prescription drug information in marketing campaigns designed to sell new drugs to physicians.  Although the law was designed to hold down health care costs and shield physicians from harassing marketing campaigns by preventing manufacturers from using prescription drug information to craft marketing campaigns,

Teva Pharmaceuticals Settles for $169 Million for Overpricing Pharmaceutical Products

Teva Pharmaceuticals, the Israeli generic pharmaceutical manufacturer, has settled, for $169 million, claims pending against it in Texas, California and Florida related to overpricing of its pharmaceutical products.  Under the scheme, Teva had provided the drugs at issue to private pharmacies including Walgreens and Wal-Mart at steeply discounted rates, but reported higher prices to the states’

Elan Pharmaceuticals Agrees to Settle Claims Related to Marketing of Zonegran for $203 Million

Elan Corporation, plc, of Dublin, Ireland has agreed to settle claims related to the marketing of Zonegran, an anti-epileptic drug for which it sold the rights to a Japanese company in 2004. In January of 2006, Elan admitted that the the DOJ and the Department of Health and Human Services were looking into its marketing practices,

U.S. Proceeds with Related Action Against Two Nursing Home Chains and Their Principals

The United States Attorney’s Office for the District of Massachusetts announced the settlement of multiple false claims act cases against Omnicare, Inc. of Covington, Kentucky,  for $98 million for soliciting and receiving multiple kickbacks.  The first scheme involved Johnson and Johnson and kickbacks for recommending that physicians prescribe Risperdal, a J&J antipsychotic drug,

Contact one of our

Experienced Attorneys

If you are aware of any person, corporation or entity that you think may be violating the Federal False Claims Act or a State False Claims Act, contact us today.